Joshua Sloan

Joshua Sloan serves as an Associate Professor in the Department of Medicine at the University of Minnesota Medical School, specializing in the Gastroenterology, Hepatology, and Nutrition Division. His clinical and research focus centers on complex esophageal disorders including eosinophilic esophagitis, gastroesophageal reflux disease, and motility abnormalities.

His primary research interests span:

• Esophageal motility disorders (EGJOO, achalasia)
• Eosinophilic esophagitis pathogenesis and treatment
• Esophageal premalignant conditions in high-risk populations
• Functional gastrointestinal disorders and neuromodulation
• Autoimmune mucosal diseases of the esophagus

His work frequently intersects with oncology, allergy, and neurogastroenterology disciplines.

Dr. Sloan leads significant clinical trials including a Phase 2 study on etrasimod for eosinophilic esophagitis. His publication trends show increasing focus on esophageal pathophysiology, clinical guidelines for motility disorders, and environmental risk factors in allergic GI diseases since 2020.

While no specific scientific awards are documented in available sources, his research contributes to UN Sustainable Development Goals related to health and well-being.

Dr. Sloan actively supervises research projects and maintains clinical collaborations focused on esophageal diseases. His laboratory work emphasizes translational studies connecting mucosal immunology with clinical phenotypes in eosinophilic disorders.